They are selling the inspection gear that keeps HBM yield from collapsing, and 30% of next year's revenue is already locked in.
Thesis: Camtek is no longer a cyclical semi-cap stock; it is a derivative on HBM yield entitlement. Advanced packaging (CoWoS/HBM) has catastrophic yield loss potential, making inspection non-discretionary. With HBM/chiplets hitting 30% of revenue in 2024 and lead times stretching to three quarters, the street is mispricing this as a legacy cycle recovery. It is a structural mix shift to higher-margin, sticky AI infrastructure.
Verdict: LONG — Conviction: HIGH
Catalyst: Q4 earnings confirming the gross margin inflection back above 50% as the high-margin HBM systems from the 42-unit order revenue recognize.
Key Risk: Capacity Ceiling - if they can't scale manufacturing fast enough to meet the 'record year' demand, they leave revenue on the table.
The Tell: Ramy Langer admitting lead times are 'two and a plus one, it's even three quarters ahead.' They usually don't have this kind of visibility. He effectively guided 2024 revenue in Q2 2023.
Friction Level: CONSENSUS
Report not found
The report data is no longer available. Please return to the archive.